Pulmonary hypertension associated with connective tissue disease

被引：62
|
作者：
Fagan, KA [1 ]
Badesch, DB [1 ]
机构：
[1] Univ Colorado, Hlth Sci Ctr, Pulm Hypertens Ctr, Denver, CO 80202 USA
来源：
PROGRESS IN CARDIOVASCULAR DISEASES | 2002年 / 45卷 / 03期
关键词：
D O I：
10.1053/pcad.2002.129975
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Pulmonary arterial hypertension is a life threatening complication of several connective tissue diseases including scleroderma (both diffuse and limited scleroderma, or the CREST syndrome - calcinosis cutis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangectasia), systemic lupus erythomatosis (SLE), mixed connective tissue disease (MCTD), and less commonly, rheumatoid arthritis (RA) and dermatomyositis/polymyositis. This report reviews the occurrence of this complication, potential etiologies, clinical presentation, and treatment options. Copyright 2002, Elsevier Science (USA). All rights reserved.
引用
收藏
页码：225 / 234
页数：10
相关论文
共 50 条
  • [21] Pulmonary hypertension associated with connective tissue diseases
    Antonio Namendys-Silva, Silvio
    Ocotlan Gonzalez-Herrera, Maria
    Luis Hernandez-Oropeza, Jose
    Rivero-Sigarroa, Eduardo
    Dominguez-Cherit, Guillermo
    REVISTA MEDICA DE CHILE, 2013, 141 (01) : 58 - 62
  • [22] Pulmonary arterial hypertension in connective tissue disease
    Cottin, V.
    REVUE DES MALADIES RESPIRATOIRES, 2006, 23 : S61 - S72
  • [23] PULMONARY HYPERTENSION AND THE IMPACT OF CONNECTIVE TISSUE DISEASE
    Condliffe, Robin
    RHEUMATOLOGY, 2016, 55 : 2 - 2
  • [24] Pulmonary Hypertension Complicating Connective Tissue Disease
    Volkmann, Elizabeth R.
    Chung, Augustine
    Saggar, Rajan
    Belperio, John A.
    Lynch, Joseph P., III
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 38 (05) : 619 - 635
  • [25] Pulmonary Hypertension Complicating Connective Tissue Disease
    Lynch, Joseph P., III
    Belperio, John A.
    Saggar, Rajeev
    Fishbein, Michael C.
    Saggar, Rajan
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (05) : 581 - 599
  • [26] IMPACT OF CONNECTIVE TISSUE DISEASE-ASSOCIATED PULMONARY HYPERTENSION ON SEPSIS HOSPITALIZATIONS
    Sinha, Rishav
    Iyer, Ishwari
    Nanavaty, Dhairya
    Devarakonda, Pradeep
    Shivalingaiah, Anuj
    Jayachamarajapura Omkaramurthy, Neema
    Pastores, Stephen
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [27] Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients
    Hao, Yan-Jie
    Jiang, Xin
    Zhou, Wei
    Wang, Yong
    Gao, Lan
    Wang, Yu
    Li, Guang-Tao
    Hong, Tao
    Huo, Yong
    Jing, Zhi-Cheng
    Zhang, Zhuo-Li
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (04) : 963 - 972
  • [28] Treprostinil (Remodulin™) in connective tissue disease-associated pulmonary hypertension.
    Oudiz, RJ
    Schilz, RJ
    Arneson, C
    Jeffs, RA
    ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2946 - 2946
  • [29] BOSENTAN & SITAXENTAN IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONNECTIVE TISSUE DISEASE
    Valerio, C.
    Handler, C.
    Denton, C. P.
    Coghlan, J. G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S168 - S168
  • [30] The Clinical Features of Pulmonary Arterial Hypertension Associated with Connective Tissue Disease in Japan
    Maki, H.
    Hatano, M.
    Minatsuki, S.
    Komuro, I.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S490 - S491
12345